4
Changes in Ownership
Arbutus Biopharma Corp Filed Acc 0001447028-24-000029
General Counsel and CCO acquired 95,100 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Naftzger J. Christopher · General Counsel and CCO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-02-01 | Grant or award : show line 1 in the form | +95,100 | 95,100 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-02-01 | Grant or award : show line 2 in the form Stock Option (Right to Buy) | +380,500 | 380,500 | D |
Loading xslF345X05/wk-form4_1707180904.xml…